Dr. Gay is an on-le advisory service for gay men and all other men who have sex wh men. Dr. Gay answers qutns about (safer) sex, homosexualy, g out, gay inty, love, relatnships, HIV/AIDS and other sexually transmted fectns as well as physil and mental health.
Contents:
- MEET THE 'RADIL GAY DOCTOR' BEHD NYC'S FALLG HIV RATE
- CYNTHIA L. GAY, MD, MPH
- DR. HANNAH GAY, WHO 'CURED' HIV-INFECTED BABY, MA 'GUTSY CALL THAT TURNED OUT TO BE CORRECT'
- DR. HANNAH GAY
- DR. CYNTHIA L. GAY
- DR. GAYDR. GAY PROMOT THE WELL-BEG OF GAY, BI & QUEER MEN THROUGH MUNY-BASED PREVENTN WORK. WE ARE AN CLIVE SERVICE: WE OFFER OUR SERVIC TO THE TRANS MUNY AS WELL. DR. GAY ANSWERS QUTNS ABOUT (SAFER) SEX, HOMOSEXUALY, G OUT, GAY INTY, LOVE, RELATNSHIPS, HIV/AIDS AND OTHER SEXUALLY TRANSMTED FECTNS AS WELL AS PHYSIL AND MENTAL HEALTH.A TEAM OF TRAED AND EXPERIENCED EDORS ANSWER QUTNS GERMAN, FRENC, ITALIAN AND ENGLISH. THEY ARE QUEER PEOPLE WH A BROAD-RANGG PROFSNAL AND PERSONAL BACKGROUND. WHERE NECSARY, THEY WILL SEEK ADVICE OM SHARE THIS PAGE BY EMAIL OR YOUR SOCIAL MEDIA CHANNELS.PRT PAGESIBARDR. GAYDR. GAY IS AN ON-LE ADVISORY SERVICE FOR GAY MEN AND ALL OTHER MEN WHO HAVE SEX WH FOOTER
- GAY DOCTOR TAK A DG TO PREVENT HIV. THEN HE ULDN'T GET DISABILY SURANCE
- HIV AND ALL GAY AND BISEXUAL MEN
MEET THE 'RADIL GAY DOCTOR' BEHD NYC'S FALLG HIV RATE
Dr. Cynthia L. Gay is a Infect Disease Specialist Chapel Hill, NC. Fd Dr. Gay's phone number, addrs, surance rmatn, hospal affiliatns and more. * dr gay hiv *
Aledo J Mena Lora, Jsi E Long, Yunda Huang, Ldsey R Ban, Hana M El Sahly, Dean Follmann, Pl Goepfert, Glenda Gray, Beatriz Grsztejn, Karen Kotloff, Nade Rouphael, Maglena Sobizczyk, Stephen R Walsh, Jsi Andrien, Karan A Shah, Yuanyuan Zhang, Peter Gilbert, Holly Jan, Cynthia L Gay, Ann R Falsey, Rebec L Tripp, Richard L Gorman, Ta Tong, Mary Marovich, Kathleen Nzil, Lawrence Corey, Jam G KublNtralizatn ter bmarker for antibody-mediated preventn of HIV-1 B Gilbert, Yunda Huang, Allan C Camp, Shelly Kana, Yuanyuan Zhang, Craig A Magaret, Elena E Grgi, Bette Korber, Pl T Edlefsen, Raabya Rossenkhan, Michal Juraska, Erika Rudnicki, Nidhi Kochar, Yg Huang, Ldsay N Carpp, Dan H Barouch, Nonhlanhla N Mkhize, Tandile Herman, Pnce Kgagudi, Valerie Bekker, Haajira Kalde, Rutendo E Mapengo, Amanda Eaton, Elize Dom, Carley Wt, Wenhong Feng, Haili Tang, Kelly E Seaton, Jack Heptstall, Carole Brackett, Kelv Chng, Geia D Tomaras, Philip Andrew, Bryan T Mayer, Daniel B Reev, Magdalena E Sobizczyk, Nigel Garrett, Je Sanchez, Cynthia Gay, Joseph Makhema, Carolyn Williamson, Jam I Mulls, John Hural, Myron S Cohen, Lawrence Corey, David C Montefri, Lynn MorrisCombed nonnonil NF-κB agonism and targeted BET bromodoma hibn reverse HIV latency ex D Falcelli, Jackson J Peterson, Anne-Marie W Turner, David Irlbeck, Jenna Read, Samuel Lm Ra, Kathere S Jam, Cameron Sutton, Anthony Sanchez, Ann Emery, Gav Sampey, Robert Ferris, Brigte Allard, Simon Ghoani, Jennifer L Kirchherr, Carole Baker, JoAnn D Kuc, Cynthia L Gay, Ldsey I Jam, Guox Wu, Pl Zuck, Inmaculada Rja, Rebec C Furze, Rab K Prjha, Bonnie J Howell, Ronald Swanstrom, Edward P Browne, Brian D Strahl, Richard M Dunham, Nancie M Arch, David M MargolisEncephalis Csed by Jamtown Canyon Vis a Liver Transplant Patient, North Carola, USA, J Cicne, Alena J Markmann, Megan L Srivas, Kara J Levson, Melissa B Miller, David van Du, Cynthia L GayEfficy and Safety of NVX-CoV2373 Adults the Uned Stat and M Dunkle, Karen L Kotloff, Cynthia L Gay, Germán Áñez, Jefey M Alglass, Alejandro Q Barrat Hernánz, Wayne L Harper, Daniel M Dunnson, Moni A McArthur, Diana F Florcu, R Stt McClelland, Veroni Garcia-Fragoso, Robert A Rienberg, David B Mante, David L Fried, Beth E Safirste, Mark McKenzie, Robert J Jeane, Jefey K Kgsley, Jefey A Henrson, Dakotah C Lane, Guillermo M Ruíz-Palacs, Lawrence Corey, Kathleen M Nzil, Robert W Coombs, Alex L Grenger, Julia Hutter, Julie A Ake, Kathere Smh, Wayne Woo, Iksung Cho, Gregory M Glenn, Filip DubovskyPopulatn molg highlights dg disposn differenc between tenofovir alafenami and tenofovir disoproxil fumarate the blood and, S. Full-length sequence analysis reveals no evince of HIV-1 replitn durg therapyLee SK, Rogers A, Xu Y, Warren J, Gooilleke N, Zhou S, Pond SK, Bednar M, Hser B, Gay C, Kuc J, Arch N, Eron J, Margolis D, Swanstrom RAltered TDF/FTC pharmalogy a transgenr female hort: Implitns for PrePCottrell, ML, Prce HM, Maffuid K, Poliseno A, Whe N, Syk C, Nelson JA, Peery A, Dellon E, Hightow-Weidman L, Adams JL, Gay C, Kashuba ARults of a Social Network Ttg Interventn for HIV Infect Disease ClicsLeViere A, Donovan J, Wilk A, Keller J, Parnell H, Sampson L, Gay CL, Qulivan EBComparg time to viral supprsn among acute and non-acute HIV North CarolaAdams DA, Cope A, Wheeler B, Mobley V, Barnhart J, Kuc JD, Gay CL, Filiatre LM, Ashby R, Samoff ET cells tablish and mata CNS viral fectn HIV-fected humanized miceHoneycutt JB, Liao B, Nixon CC, Cleary RA, Thayer WO, Birath SL, Swanson MD, Sheridan P, Zakharova O, Prce F, Kuc J, Gay CL, Evans C, Eron JJ, Wahl A, Garcia JVVirologil and immunologil rpons to raltegravir and dolutegravir the gut-associated lymphoid tissue of HIV-fected men and womenWeber MD, Andrews E, Prce HA, Syk C, Rosen EP, Bay C, Shaheen NJ, Madanick RD, Dellon ES, De Paris K, Nelson JA, Gay CL, Kashuba ADTreatment of acute HIV wh elvegravir, bicistat, emtriciabe and tenofovirMcGee K, Filiatre L, Crooks A, Gay C, Kuc J, Hicks C, Eron J, Margolis DM, Ferrari G, McKellar MDifferential antiretroviral lolizatn and dg transporter exprsn wh gut-associated lymphoid tissue of HIV+ subjects: parison to pre-clil speciThompson CG, Prce HA, Fallon JK, Rosen EP, Syk C, Mathews M, Arora S, Dellon ES, Peery A, Shaheen N, Gay C, Luciw PA, Akka R, Garcia JV, Smh PC, Kashuba ADMVorostat renrs the replitn-petent latent rervoir of HIV vulnerable to clearance by CD8 T cellSung J, Bednar M, Joseph S, Sholtis K, Kuc J, Gay C, Swanstrom R, Nordstrom J, Bollard C, Arch N, Margolis DPhylodynamic analysis aids partner servic by intifyg unreported transmissnCampbell E, Shankar A, Wtheimer E, Gay CL, Cohen SE, Li JF, Johnson JA, Peters PJ, Swzer WMN/AEvans M, Patala A, Campbell E, Wtheimer E, Gay CL, Cohen SE, Swzer WM, Peters PJHIV Persistence Gut-Associated Lymphoid Tissu: Pharmalogil Challeng and OpportuniThompson CG, Gay CL, Kashuba ADMSgle-dose pharmaketics of tenofovir alafenami and s active metabole the musal tissuCottrell ML, Garrett KL, Prce HMA, Syk C, Scher A, Emerson CW, Peery A, Rooney JF, McCallister S, Gay C, Kashuba ADMInterval dosg wh the HDAC hibor vorostat effectively revers HIV latencyArch NM, Kirchherr JL, Sung JA, Clutton G, Sholtis K, Xu Y, Allard B, Stuelke E, Kashuba AD, Kuc JD, Eron J, Gay CL, Gooilleke N, Margolis DMIntegratg a statewi HIV ll le: an novative and tailored approach for rapid lkage to HIV reColeman TE, LeViere A, Carno J, Bailey M, Hee A, Qulivan EB, Gay CVorostat Renrs the Replitn-Competent Latent Rervoir of Human Immunoficiency Vis (HIV) Vulnerable to Clearance by CD8 T CellsSung JA, Sholtis K, Kirchherr J, Kuc JD, Gay CL, Nordstrom JL, Bollard CM, Arch NM, Margolis DMEvaluatn of Abbott ARCHITECT HIV Combo signal to cutoff rat and ambiguo nucleoti equency as markers of HIV fectn duratnPorter S, Lecher S, Shankar A, Wtheier E, Gay C, Cohen S, Campbell E, Sigalo N, Rose, Zhou J, Li J, Johnston J, Swzer W, Peters PEffective Disease Interventn Is Key Component to Acute HIV DetectnKuc J, Willis S, Dzialowy N, Maxwell J, Barnhart J, Mobley V, Gay C, Sarnoff EConcentratns of TFV and TFVdp Female Musal Tissu After a Sgle Dose of TAFGarrett K, Cottrell M, Prce H, Syk C, Scher A, Peery A, Rooney J, McCallister S, Gay C, Kashuba ASafety, immunologic and virologic activy of anti-PD-L1 HIV-1 participants on ARTEron JJ, Gay C, Bosch R, Rz J, Hataye JM, Hwang C, Trsler RL, Mason SM, Koup RA, Mellors JW, for the ACTG A5326 Study TeamEffect of Acute HIV Infectn on CD4/CD8 Normalizatn After ART IniatnDavy T, Napravnik S, Cope A, Kuc J, Gay C, Eron JNrognive Improvement Wh NRTI-Sparg Treatment Acute HIV InfectnGay C, Willis S, Kuc J, McGee K, Kashuba A, McKellar M, Hicks C, Eron J, Margolis D, Robertson KTen Years of Screeng and Ttg for Acute HIV Infectn North CarolaKuc JD, Cope AB, Sampson LA, Gay CL, Ashby RM, Fot EM, Brson M, Barnhart JE, Margolis D, Miller WC, Leone PA, Eron JJFixed-dose batn emtricabe/tenofovir/efavirenz iated durg acute HIV fectn; 96-week efficy and durabilyGay CL, Willis SJ, Cope AB, Kuc JD, McGee KS, Sebastian J, Crooks AM, McKellar MS, Margolis DM, Fisc SA, Hicks CB, Ferrari G, Eron JJ; De-UNC Acute HIV Infectn ConsortiumCorrigendum: The differential short- and long-term effects of HIV-1 latency-reversg agents on T cell functnClutton G, Xu Y, Baldoni PL, Mollan KR, Kirchherr J, Newhard W, Cox K, Kuc JD, Kashuba A, Barnard R, Arch N, Gay CL, Hudgens MG, Margolis DM, Gooilleke NCost Effectivens of Addg 4th-Generatn Immunoassay Screeng After a Negative Rapid HIV TtHutchson A, Cohen S, Wtheimer E, Gay C, Marseille E, Hall L, Hightow-Weidman L, Tsoi B, Pandori M, Peters PCare-Cas Stat of Partners of Persons Wh New HIV Infectns North CarolaCope A, Hightow-Weidman L, Kuc J, Marmoro J, Beagle S, Gay C, Peters POngog HIV Transmissn and the HIV Care Contuum North CarolaCope AB, Powers KA, Kuc JD, Leone PA, Anrson JA, Pg LH, Kcer LP, Swanstom R, Mobley VL, Fot E, Gay CL, Eron JJ, Cohen MS, Miller WCUnreported male sex partners among men wh newly diagnosed HIV fectn - North Carola, 2011-2013Wu H, Hightow-Weidman LB, Gay CL, Zhang X, Beagle S, Hall L, Jackson T, Marmoro J, Do AN, Peters PJDual-affy re-targetg protes direct T cell-mediated cytolysis of latently HIV-fected cellsSung JA, Pickeral J, Liu L, Stanfield-Oakley SA, Lam CK, Garrido C, Pollara J, LaBranche C, Bonsignori M, Moody MA, Yang Y, Parks R, Arch N, Allard B, Kirchherr J, Kuc JD, Gay CL, Cohen MS, Ochsenber C, Sorberg K, Liao HX, Montefri D, Moore P, Johnson S, Koenig S, Hayn BF, Nordstrom JL, Margolis DM, Ferrari GPrelimary Asssment of the Nrognive Effects of Vorostat Admistratn HIV EraditnRobertson K, Kuc J, Gay C, Arch N, Eron J, Margolis DHIV Infectn Among Partners of HIV-Infected Black Men Who Have Sex wh Men - North Carola, 2011-2013Peters PJ, Gay C, Beagle S, Shankar A, Swzer WM, Hightow-Weidman LB; Centers for Disease Control and Preventn (CDC)Measurg HIV latency over time: rervoir stabily and asssg terventnsArch N, Crooks A, Baton R, Cope AB, Dahl NP, Eron JJ, Gay CL, Kuc JD, Margolis DM, Bosch RJImmunogenicy of AGS-004 Dendric Cell Therapy Patients Treated durg Acute HIV InfectnGay C, Arch N, Tcherepanova I, Villiard E, Hicks C, Kearney M, Coff J, DeBenette, M, Eron J, Nillette C, Margolis DMCost effectivens of addg 4th-generatn immunoassay screeng after a negative rapid HIV ttHutchson A, Cohen S, Wtheimer E, Gay C, Marseille E, Hall L, Hightow-Weidman LB, Tsoi B, Pandori M, Peters PJPartners of Individuals wh Acute HIV Infectn have a High Frequency of Known HIV InfectnPeters PJ, Wtheimer E, Cohen S, Rose C, Gay C, Jackson B, Hightow-Weidman LB, Hall LImplementatn of a Collaborative HIV Ttg Mol between an Emergency Department and Infect Disease ClicHoots BE, Kle PW, Leone PA, Qulivan EB, Larson JL, Young JE, Miller MB, and Gay CLDetectn of acute HIV fectn two evaluatns of a new HIV diagnostic ttg algorhm � Uned Stat, 2011-2013CDC. )HIV Combatn Antigen / Antibody Ttg Detects a High Proportn of Acute HIV Infectns and Improv HIV Diagnostic Yield�Three Regns of the Uned StatPeters PJ, Wtheimer E, Moss N, Gay C, Tsoi B, Pandori MW, Hightow-Weidman LB, Hall L, Patel P, for the STOP study group�No one�s at home and they won�t pick up the phone�: Usg the Inter and SMS to Enhance Partner Servic North CarolaHightow-Weidman LB, Beagle S, Embry J, Pike E, Kuc J, Leone P, Fot E, Gay CSelective HIV RNA screeng of specimens that are non-reactive by 4th generatn HIV ttg n intify addnal fectns: lsons om the STOP StudyMoss N, Rose C, Gay C, Hall L, Hightow-Weidman L, Tsoi B, Wtheimer E, Peters PJ, Pandori MThe Multispot rapid HIV-1/HIV-2 differentiatn assay is parable wh the Wtern blot and an immunofluorcence assay at nfirmg HIV fectn a prospective study three regns of the Uned StatPandori MW, Wtheimer E, Gay C, Moss N, Fu J, Hightow-Weidman LB, Craw J, Hall L, Giantti FR, Mak ML, Madayag C, Tsoi B, Louie B, Patel P, Owen SM, Peters PJPatient retentn om HIV diagnosis through one year on antiretroviral therapy at a primary healthre clic Johannburg, South AiCloe K, Pettifor AE, Maskew M, Bassett J, Van Rie A, Behets F, Gay C, Sanne I, Fox MPVery low rat of adverse events (AEs) durg rapid sle-up of voluntary medil male circumcisn (VMMC) servic both fixed s and outreach mpaigns TanzaniaMphu L, McMahan J, Cala J, Gay C, Bianchi F, Mandali H, Mbekem G, Kazra K, Benech IIncint sexually transmted fectn as a bmarker for high risk sexual behavr after enterg re dividuals diagnosed wh acute HIVCope AB, Crooks A, Kuc J, Sugarbaker A, Hightow-Weidman LB, Eron J, Gay CIniatn of ART at higher CD4 unts unr South Ai's revised antiretroviral therapy guil rults improved patient outCloe K, Pettifor A, Maskew M, Bassett J, Van Rie A, Gay C, Behets F, Sanne I, Fox MPPatient retentn at key ton after HIV diagnosis at a primary health clic Johannburg, South AiCloe K, Pettifor A, Maskew M, Bassett J, Van Rie A, Gay C, Behets F, Sanne I, Fox MPSexually transmted fectn cince as a bmarker for high risk sexual behavr after enterg re dividuals diagnosed wh acute HCope AB, Crooks A, Kuc J, Sugarbaker A, Hightow-Weidman L, Eron E, Gay CInter partner notifitn servic: improved out through llaboratn and centralizatn of activiHightow-Weidman LB, Beagle B, Gay C, Kuc J, Embry J, Pike E, Vanhoy T, Fot E, Leone PAIncreasg trend Ain-Amerin, MSM and younger age among acutely fected persons tected through the North Carola acute HIV programKuc J, Cope A, Zadrozny S, Barnhart J, Sampson L, Brson M, Fot E, Eron J, Gay C, Leone PAntiretroviral therapy started durg acute HIV fectn failed to prevent persistent immune activatnVikoor M, Cope A, Gay C, Ferrari G, McGee K, Kuc J, Hicks C, Margolis D, and Eron JSexually transmted fectn cince as a bmarker for high risk sexual behavr after enterg re dividuals diagnosed wh acute HIVAB Cope, A Crooks, J Kuc, A Sugarbaker, L Hightow-Weidman L, J Eron, C GayCD4+CD8+ T Cells Reprent a Signifint Portn of the Anti-HIV T Cell Rponse to Acute HIV InfectnFrahm MA, Pickg RA, Kuc JD, McGee KS, Gay CG, Eron JJ, Hicks CB, Tomaras GD, Ferrari GLate HIV diagnosis: A statewi program offerg ee CD4 unt ttg and accs to rults North CarolaGay C, Kuc J, Embry J, Bishof J, Ashby R, Vanhoy T, Clymore J, Fot E, Leone PProspective Study of the HIV Combo 4th generatn assay to tect HIV fectn STI clics � The START StudyGay C, Kuc J, Bischof J, Embry J, Hatch J, Ashton F, Schmz J, Miller W, Leone POraquick ttg utilizatn a high risk patient populatnWhmore J, Bishof J, Bell L, Pierce J, Hee A, Qulivan E, Cooper K, Gay CNon-lear y of rtg CD4 cell fectn after antiretroviral therapy durg acute, seronegative HIV fectn suggts the prence of distct RCI populatnsArch N, Dahl N, Le A, Kuc J, Scepanski J, Cohen M, Gay C, Eron J, Margolis DThe Women at Risk Programme Hillbrow (Inner-cy Johannburg) � sex worker accs health re servicSibanyoni M, Gay C, Venter WDF, Motlokoa N, Klaas KRelatnship between functnal profile of HIV-1 specific CD8 T cells and epope variabily wh the selectn of pe mutants acute HIV-1 fectnFerrari G, Korber B, Gooilleke N, Liu MK, Turnbull EL, Salazar-Gonzalez JF, Hawks N, Self S, Watson S, Betts MR, Gay CL, McGee K, Pellegro P, Williams I, Tomaras GD, Hayn BF, Gray CM, Borrow P, Roerer M, McMichael AJ, Wehold KJProspective study of the ARCHITECT HIV Ag/Ab Combo fourth generatn assay to tect HIV fectn sexually transmted fectn clicsBishoff JJ, Kuc JD, Embry JA, Hatch JE, Ashton FA, Schmz JL, Miller WC, Leone PA, Gay CLEmergency Department HIV Ttg and the Re-engagement of HIV-Posive Patients medil CareKle PW, Hoots BE, Gay CL, Leone PAEffect of Opt-out Ttg on Ttg Rat Among High-Risk Individuals Sexually Transmted Disease (STD) ClicsBrouwer EB, Napravnik S, Sey SG, Swygard H, Sena AC, Leone PA, Fot E, Cohen MS, Qulivan EB, Gay CL, Hightow-Weidman LB, McCloy EC, Patterson K, Eron JJCorrelatn of peak and duratn of viremia and rtg CD4+ T-cell fectn Acute HIV InfectnArch N, Vaidya1 N, Cheema M, Sackmann R, Sugarbaker A, Scepanski J, Kuc J, Gay C, Cohen M, Eron J, Perelson A, Margolis DMMissed Opportuni for STD and HIV Ttg a North Carola Emergency DepartmentKle PW, Hoots BE, Gay CL, Moore PR, Stt JL, Leone PAThe gap between HIV fectn and advanc HIV treatmentGay CImplementatn of a Collaborative HIV Ttg Mol a North Carola Emergency DepartmentKle PW, Hoots BE, Leone PA, Qulivan EB, Gay CLUnrstandg Delays HIV Care Iniatn the Southeastern USNapravnik S, Brower ES, Qulivan EB, Leone PA, Fot EM, Cohen MS, Sena AC, Gay CL, Hightow-Weidman LB, Patterson KB, Stalzer B, Case M, Swygard H, Eron JJCHAVI 001 Offers Improved Clil Care, Counselg and HIV/AIDS Related Referral to Patients at UNC Project-Kamuzu Central Hospal STI ClicKamanga G, Mapanje C, Nyirenda N, Nyirenda C, Reynolds K, Kharodia S, Phakati S, Martson F, McCley M, Gay C, Hoffman I, Cohen MEvaluatn of six years of statewi screeng and ttg for acute HIV fectn North CarolaKuc, J, Mayo A, Sampson L, Barnhart J, Brson M, McCoy S, Fot E, Ashby R, Pilcher C, Gay C, Leone P, Eron JRtg CD4+ T cell fectn is limed by antiretroviral therapy durg acute fectn, and appears rrelated wh total exposure to viremiaArch N, Parker D, Sugarbaker A, Kuc J, Hicks C, McCley M, Cohen M, Eron J, Gay C, and Margolis D, for the NC STAT Program and the NIH CHAVIImplementatn of a llaborative HIV ttg mol between an emergency partment and fect diseas clic North CarolaHoots B, Leone P, Qulivan E, Gay CAn evaluatn of syphilis outbreak rponse plans, 2005-2006Myl R, Beltrami J, Carey D, Gay C, O�Connor K, Groseclose SPartner unselg and referral out after acute HIV intifitn North CarolaMcCoy S, Kuc J, Gay C, Hurt C, Anrson J, Pilcher C, Barnhart J, Eron J, Leone P, and the North Carola STAT TeamIntifyg Individuals wh Acute HIV Who Prent to an STI Clic Lilongwe, MalawiKamangan G, Kwaana D, Nyirenda N, Kanyamula H, Mapanje C, Namakhwa D, Reynolds K, Martson F, Gay C, McCley M, Hoffman I, Cohen MHigh prevalence of acute HIV fectn SubSaharan Ai: a cross sectnal, multi-centre screeng studyKamanga G, Thumbi P, Nkhoma M, Manamela P, Bogoshi M, Berdg J, Latka M, Martson F, Abdool Karim S, Kumwenda J, Re H, Churchyard G, McCley M, Gay C, Cohen M, for the CHAVI Clil CoreEfficy of NNRTI-based antiretroviral therapy iated durg acute HIV fectnGay C, Johnson A, McCoy S, Kuc J, McGee K, McNeil L, Kerk M, Sebastian J, Pilcher C, Margolis D, Leone P, Fisc S, Ferrari G, Hicks C, Eron J, The De-UNC Acute HIV Infectn ConsortiumEffect(s) of antiretroviral treatment on acute HIV fectnGay C, Dibben D, Stacey A, Gasper-Smh N, Liu M, Norris P, Gooilleke N, Ferrari G, Eron J, Hicks C, McMichael A, Hayn B, Borrow P, Cohen M, on behalf of the De-UNC CHAVI 001 Clil Workg GroupHigh Prevalence of acute HIV fectn SubSaharan Ai: A cross sectnal, multi-centre screeng studyKamanga G, Thumbi P, Nkhoma M, Manamela P, Bogoshi M, Berdg J, Latka M, Martson F, Karim S Abdool, Kumwenda J, Re H, Churchyard G, McCley M, Gay C, Cohen M, for the CHAVI Clil CoreN/AGay C, Kashuba A and Cohen MAcute HIV fectn: the impact of anti-retroviral treatment on cellular immune rponsHicks CB, Gay C, Ferrari GAntiretroviral treatment of acute HIV fectn: symptomatic bias, cytok, apoptosis and cell mediated rponsGay C, Stacey A, Gasper-Smh N, Liu M, Dibben O, Gooilleke N, Ferrari G, Eron J, Hicks C, McMichael A, Hayn B, Borrow P, Cohen M, on behalf of the De-UNC CHAVI 001 Clil Workg GroupAntiretroviral therapy for preventn of the sexual transmissn of HIV-1Cohen MS, Gay C, Kashuba A, Blower S, Paxton LAcute HIV revised: new opportuni for treatment and preventn J Cl Invt 2004 Apr;113(7):937-45 ReviewPilcher CD, Eron JJ Jr, Galv S, Gay C, Cohen MSHIV antiretroviral postexposure prophylaxis: a utnary noteCohen MS, Kashuba AD, Gay CLate prentatn to re for HIV the southeastern Uned Stat and associated risk factorsGay C, Napravnik S, Eron JHIV-Specific, Ex Vivo Expand T Cell Therapy: Feasibily, Safety, and Efficy ART-Supprsed HIV-Infected IndividualsPatrick J.
CYNTHIA L. GAY, MD, MPH
* dr gay hiv *
DR. HANNAH GAY, WHO 'CURED' HIV-INFECTED BABY, MA 'GUTSY CALL THAT TURNED OUT TO BE CORRECT'
The high percentage of gay and bisexual men who are livg wh HIV means that, as a group, they have a greater risk of beg exposed to HIV; browse lks here. * dr gay hiv *